Last summer the American Cancer Society (ACS) announced that Lin MacMaster had been hired as its first-ever Chief Revenue and Marketing Officer, a senior leadership position that combined the formerly separate functions of fundraising and marketing.
The society stated in a press release at that time that adding MacMaster to the "seminal post" was "... part of a transformative effort designed to save even more lives from cancer."
Less than 18 months later that executive is gone, and the ACS is facing a projected $40-million revenue loss linked to an especially poor showing from its hallmark
events.
Source: MedPage Today
Read the full story:
Ide-cel Shows Benefit vs Standard Regimens in Heavily Pretreated R/R Multiple Myeloma
March 30th 2023Idecabtagene vicleucel (ide-cel) led to significantly longer PFS and better therapy responses than standard regimens for patients with triple-class–exposed relapsed and refractory multiple myeloma.
Read More
Bridging the Gap in Health Care Inequities: Considerations in Treatment Selection: Part 1
March 30th 2023In part 1 of this 2-part series on health equity in the treatment of psoriasis, Ryan Haumschild, PharmD, and Bryan Buckley, DrPH, discuss how providers can address disparities in care, specifically with race, cultural, and ethnic backgrounds in mind.
Listen
More Needs to Be Done to Reduce Racial Disparities in Home Dialysis
March 24th 2023On this episode of Managed Care Cast, we speak with Virginia Wang, PhD, and Matthew L. Maciejewski, PhD, who talk about their recent study on racial disparities in home dialysis, and what more needs to be done to increase uptake and reduce disparities in home dialysis for non-White patients.
Listen
2 Clarke Drive
Cranbury, NJ 08512